The estimated Net Worth of Capital Management, Llcaldr... is at least $65.7 Millón dollars as of 17 November 2008. Capital Llcaldr owns over 44,887 units of Biospecifics Technologies stock worth over $65,706,612 and over the last 16 years Capital sold BSTC stock worth over $0.
Capital has made over 3 trades of the Biospecifics Technologies stock since 2008, according to the Form 4 filled with the SEC. Most recently Capital bought 44,887 units of BSTC stock worth $748,715 on 17 November 2008.
The largest trade Capital's ever made was buying 44,887 units of Biospecifics Technologies stock on 17 November 2008 worth over $748,715. On average, Capital trades about 21,994 units every 18 days since 2008. As of 17 November 2008 Capital still owns at least 742,196 units of Biospecifics Technologies stock.
You can see the complete history of Capital Llcaldr stock trades at the bottom of the page.
Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo y Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.
Biospecifics Technologies executives and other stock owners filed with the SEC include: